Skip to main content

Animations

MJFF Publications

5971 - 5980 of 6433 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Swarm Learning for decentralized and confidential clinical machine learning
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41586-021-03583-3
    Citation Count: 765
  • Summary Details
    OPEN
    Title: Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202114022
    Citation Count: 171
  • Summary Details
    OPEN
    Title: Novel Associations of BST1 and LAMP3 With REM Sleep Behavior Disorder
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000011464
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Association of Mitochondrial DNA Genomic Variation With Risk of Pick Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000011649
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-22399-3
    Citation Count: 69
  • Summary Details
    OPEN
    Title: Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02285-4
    Citation Count: 48
  • Summary Details
    OPEN
    Title: In situ architecture of neuronal α-Synuclein inclusions
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-22108-0
    Citation Count: 103
  • Summary Details
    OPEN
    Title: High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xpro.2021.100463
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13168
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research
    Journal Name: Trials
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13063-021-05273-x
    Citation Count: 33
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.